Clinical Trials Directory

Trials / Unknown

UnknownNCT06180031

Effect of Adding Magnesium Sulphate in Pericapsular Nerve Group Block

Effect of Adding Magnesium Sulphate to Bupivacaine in Ultrasound Guided Pericapsular Nerve Group Block for Post Operative Analgesia in Hip Joints Surgeries

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Our aim will be to compare the analgesic efficacy and safety of magnesium sulphate as an adjuvant to bupivacaine in pericapsular nerve group block in Hip joint surgeries. * Our primary outcome of the study: total amount of postoperative morphine consumption in the first 24h postoperative. * Our secondary outcome of the study: mean arterial blood pressure, heart rate, respiratory rate, adverse effects, block related complication, sedation score (by Ramsay sedation scale) and pain score (by Visual Analog Scale)

Conditions

Interventions

TypeNameDescription
DRUGPericapsular nerve group block using bupivicaine and magnesium sulphateThis technique involves the deposition of the local anesthetic in the fascial plane between the psoas muscle and the superior pubic ramus

Timeline

Start date
2024-01-01
Primary completion
2025-01-01
Completion
2025-03-30
First posted
2023-12-22
Last updated
2023-12-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06180031. Inclusion in this directory is not an endorsement.

Effect of Adding Magnesium Sulphate in Pericapsular Nerve Group Block (NCT06180031) · Clinical Trials Directory